Arlington Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,757
Closed -$675K 412
2023
Q2
$675K Hold
8,757
0.1% 71
2023
Q1
$658K Buy
8,757
+6,910
+374% +$514K 0.09% 68
2022
Q4
$146K Buy
1,847
+1,177
+176% +$88.2K 0.02% 114
2022
Q3
$47K Hold
670
0.02% 199
2022
Q2
$54K Hold
670
0.02% 238
2022
Q1
$51K Sell
670
-101
-13% -$8K 0.01% 246
2021
Q4
$66K Buy
771
+101
+15% +$7.89K 0.02% 253
2021
Q3
$51K Sell
670
-33
-5% -$2.62K 0.01% 258
2021
Q2
$57K Hold
703
0.02% 185
2021
Q1
$55K Buy
703
+33
+5% +$2.59K 0.02% 229
2020
Q4
$57K Hold
670
0.03% 104
2020
Q3
$52K Sell
670
-37
-5% -$2.82K 0.03% 102
2020
Q2
$52K Hold
707
0.03% 101
2020
Q1
$47K Buy
707
+37
+6% +$2.61K 0.02% 120
2019
Q4
$46K Hold
670
0.03% 125
2019
Q3
$49K Buy
+670
New +$48.6K 0.03% 102
2019
Q2
Sell
-670
Closed -$46K 221
2019
Q1
$46K Hold
670
0.03% 121
2018
Q4
$40K Hold
670
0.03% 118
2018
Q3
$45K Hold
670
0.03% 135
2018
Q2
$43K Hold
670
0.04% 79
2018
Q1
$48K Hold
670
0.05% 76
2017
Q4
$51K Buy
+670
New +$48.9K 0.05% 80

Other funds holding CL

Arlington Partners's CL Position: Q3 2023 in Review

Arlington Partners sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 8,757 shares — an estimated $675K sold.

Arlington Partners first reported a position in CL in Q4 2017 and held it in 22 quarters. The position peaked at $675K in Q2 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Arlington Partners reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Arlington Partners sold 8,757 Colgate-Palmolive shares in Q3 2023, an estimated $675K.
  • Arlington Partners first reported a position in Colgate-Palmolive in Q4 2017 and held it in 22 quarters.
  • Arlington Partners's Colgate-Palmolive position peaked at $675K in Q2 2023.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.